Condition
Basal Cell Carcinoma (BCC) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Basal Cell Carcinoma (BCC) clinical trials that are recruiting, at sites in 2 countries (most in Germany (1), United States (1)). By phase: Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Cemiplimab as first-line treatment for advanced basal cell carcinoma
This trial will try cemiplimab as a first-line treatment for adults with locally advanced basal cell carcinoma who have not received hedgehog inhibitors.
-
Blue-light photodynamic therapy plus sonidegib for multiple basal cell skin cancers
This will try combining blue-light photodynamic therapy with the oral drug sonidegib to treat adults who have three or more nodular basal cell skin cancers.
Related topics
Quick answers
How many Basal Cell Carcinoma (BCC) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Germany (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.